{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:06:19Z","timestamp":1790658379519,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s40618-020-01384-5","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T18:04:00Z","timestamp":1598637840000},"page":"693-701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["What we have to know about corticosteroids use during Sars-Cov-2 infection"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7472-6598","authenticated-orcid":false,"given":"F.","family":"Ferra\u00f9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ceccato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cannav\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Scaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"1384_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/14651858.CD010406","volume-title":"Cochrane Database of Systematic Reviews Chichester","author":"C Rodrigo","year":"2013","unstructured":"Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS (2013) Corticosteroids as adjunctive therapy in the treatment of influenza. In: Lim WS (ed) Cochrane Database of Systematic Reviews Chichester. John Wiley and Sons, UK, pp 98\u2013106. https:\/\/doi.org\/10.1002\/14651858.CD010406"},{"issue":"2","key":"1384_CR2","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/CCM.0000000000004093","volume":"48","author":"LE Lansbury","year":"2020","unstructured":"Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Shen LW (2020) Corticosteroids as adjunctive therapy in the treatment of influenza: an updated cochrane systematic review and meta-analysis. Crit Care Med 48(2):e98\u2013e106. https:\/\/doi.org\/10.1097\/CCM.0000000000004093","journal-title":"Crit Care Med"},{"issue":"4","key":"1384_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","volume":"31","author":"N Lee","year":"2004","unstructured":"Lee N, Allen Chan KC, Hui DS et al (2004) Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol 31(4):304\u2013309. https:\/\/doi.org\/10.1016\/j.jcv.2004.07.006","journal-title":"J Clin Virol"},{"key":"1384_CR4","doi-asserted-by":"publisher","first-page":"CD007720","DOI":"10.1002\/14651858.CD007720.pub3","volume":"12","author":"A Stern","year":"2017","unstructured":"Stern A, Skalsky K, Avni T, Carrara E, Leibovici L, Paul M (2017) Corticosteroids for pneumonia. Cochrane database Syst Rev 12:CD007720. https:\/\/doi.org\/10.1002\/14651858.CD007720.pub3","journal-title":"Cochrane database Syst Rev"},{"key":"1384_CR5","doi-asserted-by":"publisher","first-page":"021436","DOI":"10.1056\/NEJMoa2021436","volume":"2","author":"RECOVERY Collaborative Group","year":"2020","unstructured":"RECOVERY Collaborative Group (2020) Dexamethasone in hospitalized patients with Covid-19 - preliminary report. N Engl J Med 2:021436. https:\/\/doi.org\/10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"1384_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01197-6","author":"F Ceccato","year":"2020","unstructured":"Ceccato F, Artusi C, Barbot M et al (2020) Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-020-01197-6","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"1384_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S2213-8587(20)30149-2","volume":"8","author":"AM Isidori","year":"2020","unstructured":"Isidori AM, Pofi R, Hasenmajer V, Lenzi A, Pivonello R (2020) Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol 8(6):472\u2013473. https:\/\/doi.org\/10.1016\/S2213-8587(20)30149-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9371","key":"1384_CR8","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","volume":"361","author":"JSM Peiris","year":"2003","unstructured":"Peiris JSM, Chu CM, Cheng VCC et al (2003) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361(9371):1767\u20131772. https:\/\/doi.org\/10.1016\/S0140-6736(03)13412-5","journal-title":"Lancet"},{"key":"1384_CR9","first-page":"9","volume":"3","author":"R Pal","year":"2020","unstructured":"Pal R, Banerjee M (2020) COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest 3:9","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"1384_CR10","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1210\/jc.2010-0982","volume":"95","author":"AB Grossman","year":"2010","unstructured":"Grossman AB (2010) The diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metab 95(11):4855\u20134863. https:\/\/doi.org\/10.1210\/jc.2010-0982","journal-title":"J Clin Endocrinol Metab"},{"key":"1384_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1421-3","author":"F Ceccato","year":"2017","unstructured":"Ceccato F, Barbot M, Albiger N et al (2017) Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma. Endocrine. https:\/\/doi.org\/10.1007\/s12020-017-1421-3","journal-title":"Endocrine"},{"issue":"8","key":"1384_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.ejim.2013.05.014","volume":"24","author":"S Dinsen","year":"2013","unstructured":"Dinsen S, Baslund B, Klose M et al (2013) Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. Eur J Intern Med 24(8):714\u2013720. https:\/\/doi.org\/10.1016\/j.ejim.2013.05.014","journal-title":"Eur J Intern Med"},{"issue":"2","key":"1384_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W et al (2016) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(2):364\u2013389. https:\/\/doi.org\/10.1210\/jc.2015-1710","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1384_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s40618-019-01146-y","volume":"43","author":"AM Isidori","year":"2020","unstructured":"Isidori AM, Arnaldi G, Boscaro M et al (2020) Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian society of endocrinology expert opinion. J Endocrinol Invest 43(5):683\u2013696. https:\/\/doi.org\/10.1007\/s40618-019-01146-y","journal-title":"J Endocrinol Invest"},{"key":"1384_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/joim.12162","volume":"4","author":"ES Husebye","year":"2014","unstructured":"Husebye ES, Allolio B, Arlt W (2014) Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 4:1. https:\/\/doi.org\/10.1111\/joim.12162","journal-title":"J Intern Med"},{"key":"1384_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01301-w","author":"A Berni","year":"2020","unstructured":"Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A (2020) Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-020-01301-w","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"1384_CR17","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1515\/cclm-2018-0824","volume":"57","author":"F Ceccato","year":"2019","unstructured":"Ceccato F, Scaroni C (2019) Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment. Clin Chem Lab Med 57(8):1125\u20131135. https:\/\/doi.org\/10.1515\/cclm-2018-0824","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"1384_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2265.2005.02325.x","volume":"63","author":"MK-S Leow","year":"2015","unstructured":"Leow MK-S, Kwek DS-K, NgAW-K O-C, Kaw GJ-L, Lee LS-U (2015) Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 63(2):197\u2013202. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02325.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1384_CR19","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-0722","author":"J \u00c1lvarez-Troncoso","year":"2020","unstructured":"\u00c1lvarez-Troncoso J, Zapatero Larrauri M, Montero Vega MD et al (2020) Case report: COVID-19 with bilateral adrenal hemorrhage. Am J Trop Med Hyg. https:\/\/doi.org\/10.4269\/ajtmh.20-0722","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"1384_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41574-019-0185-7","volume":"15","author":"A T\u00e9blick","year":"2019","unstructured":"T\u00e9blick A, Peeters B, Langouche L, Van den Berghe G (2019) Adrenal function and dysfunction in critically ill patients. Nat Rev Endocrinol 15(7):417\u2013427. https:\/\/doi.org\/10.1038\/s41574-019-0185-7","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1384_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1196\/annals.1366.027","volume":"1088","author":"SR Bornstein","year":"2006","unstructured":"Bornstein SR, Ziegler CG, Krug AW et al (2006) The role of toll-like receptors in the immune-adrenal crosstalk. Ann N Y Acad Sci 1088(1):307\u2013318. https:\/\/doi.org\/10.1196\/annals.1366.027","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"1384_CR22","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00134-010-1971-9","volume":"36","author":"YS Kwon","year":"2010","unstructured":"Kwon YS, Suh GY, Jeon K et al (2010) Serum cytokines and critical illness-related corticosteroid insufficiency. Intensive Care Med 36(11):1845\u20131851. https:\/\/doi.org\/10.1007\/s00134-010-1971-9","journal-title":"Intensive Care Med"},{"issue":"12","key":"1384_CR23","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00134-017-4919-5","volume":"43","author":"D Annane","year":"2017","unstructured":"Annane D, Pastores SM, Rochwerg B et al (2017) Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): society of critical care medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med 43(12):1751\u20131763. https:\/\/doi.org\/10.1007\/s00134-017-4919-5","journal-title":"Intensive Care Med"},{"issue":"10","key":"1384_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1742-1241.2011.02718.x","volume":"65","author":"P Reddy","year":"2011","unstructured":"Reddy P (2011) Clinical approach to adrenal insufficiency in hospitalised patients. Int J Clin Pract 65(10):1059\u20131066. https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02718.x","journal-title":"Int J Clin Pract"},{"issue":"4","key":"1384_CR25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s00134-017-4951-5","volume":"44","author":"SM Pastores","year":"2018","unstructured":"Pastores SM, Annane D, Rochwerg B (2018) Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med 44(4):474\u2013477. https:\/\/doi.org\/10.1007\/s00134-017-4951-5","journal-title":"Intensive Care Med"},{"issue":"6","key":"1384_CR26","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1210\/jc.2015-1218","volume":"100","author":"LHA Broersen","year":"2015","unstructured":"Broersen LHA, Pereira AM, J\u00f8rgensen JOL, Dekkers OM (2015) Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab 100(6):2171\u20132180. https:\/\/doi.org\/10.1210\/jc.2015-1218","journal-title":"J Clin Endocrinol Metab"},{"key":"1384_CR27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00153","author":"TF Mebrahtu","year":"2019","unstructured":"Mebrahtu TF, Morgan AW, Keeley A, Baxter PD, Stewart PM, Pujades-Rodriguez M (2019) Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2019-00153","journal-title":"J Clin Endocrinol Metab"},{"key":"1384_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01293-7","author":"L Bartalena","year":"2020","unstructured":"Bartalena L, Chiovato L, Marcocci C, Vitti P, Piantanida E, Tanda ML (2020) Management of Graves\u2019 hyperthyroidism and orbitopathy in time of COVID-19 pandemic. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-020-01293-7","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1384_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000440834","volume":"4","author":"S Jespersen","year":"2015","unstructured":"Jespersen S, Nygaard B, Kristensen L\u00d8 (2015) Methylprednisolone pulse treatment of Graves\u2019 ophthalmopathy is not associated with secondary adrenocortical insufficiency. Eur Thyroid J 4(4):222\u2013225. https:\/\/doi.org\/10.1159\/000440834","journal-title":"Eur Thyroid J"},{"issue":"4","key":"1384_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1089\/thy.2014.0533","volume":"25","author":"Z Giotaki","year":"2015","unstructured":"Giotaki Z, Fountas A, Tsirouki T, Bargiota A, Tigas S, Tsatsoulis A (2015) Adrenal reserve following treatment of Graves\u2019 orbitopathy with intravenous glucocorticoids. Thyroid 25(4):462\u2013463. https:\/\/doi.org\/10.1089\/thy.2014.0533","journal-title":"Thyroid"},{"issue":"0123456789","key":"1384_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s40618-020-01253-1","volume":"2","author":"C Scaroni","year":"2020","unstructured":"Scaroni C, Armigliato M, Cannav\u00f2 S (2020) COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency? J Endocrinol Invest 2(0123456789):3\u20134. https:\/\/doi.org\/10.1007\/s40618-020-01253-1","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"1384_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/psb.1060","volume":"24","author":"A Iliopoulou","year":"2013","unstructured":"Iliopoulou A, Abbas A, Murray R (2013) How to manage withdrawal of glucocorticoid therapy. Prescriber 24(10):23\u201329. https:\/\/doi.org\/10.1002\/psb.1060","journal-title":"Prescriber"},{"issue":"4","key":"1384_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/MED.0b013e3283631820","volume":"20","author":"KH Darzy","year":"2013","unstructured":"Darzy KH (2013) Radiation-induced hypopituitarism. Curr Opin Endocrinol Diabetes Obes 20(4):342\u2013353. https:\/\/doi.org\/10.1097\/MED.0b013e3283631820","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"1384_CR34","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1365-2265.2006.02506.x","volume":"64","author":"G Minniti","year":"2006","unstructured":"Minniti G, Traish D, Ashley S, Gonsalves A, Brada M (2006) Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clin Endocrinol (Oxf) 64(5):542\u2013548. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02506.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1384_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jns.2016.11.024","volume":"372","author":"X Li","year":"2017","unstructured":"Li X, Li Y, Cao Y et al (2017) Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: a systematic review and meta-analysis. J Neurol Sci 372:110\u2013116. https:\/\/doi.org\/10.1016\/j.jns.2016.11.024","journal-title":"J Neurol Sci"},{"issue":"8","key":"1384_CR36","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1210\/jc.2011-0306","volume":"96","author":"NM Appelman-Dijkstra","year":"2011","unstructured":"Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM et al (2011) Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J Clin Endocrinol Metab 96(8):2330\u20132340. https:\/\/doi.org\/10.1210\/jc.2011-0306","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1384_CR37","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/cen.12969","volume":"84","author":"N Kyriakakis","year":"2016","unstructured":"Kyriakakis N, Lynch J, Orme SM et al (2016) Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours. Clin Endocrinol (Oxf) 84(3):372\u2013379. https:\/\/doi.org\/10.1111\/cen.12969","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"1384_CR38","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1210\/jc.2010-0144","volume":"95","author":"A Tsiakalos","year":"2010","unstructured":"Tsiakalos A, Xynos ID, Sipsas NV, Kaltsas G (2010) Pituitary insufficiency after infectious meningitis: a prospective study. J Clin Endocrinol Metab 95(7):3277\u20133281. https:\/\/doi.org\/10.1210\/jc.2010-0144","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1384_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11102-016-0757-7","volume":"20","author":"L Gao","year":"2017","unstructured":"Gao L, Guo X, Tian R et al (2017) Pituitary abscess: clinical manifestations, diagnosis and treatment of 66 cases from a large pituitary center over 23 years. Pituitary 20(2):189\u2013194. https:\/\/doi.org\/10.1007\/s11102-016-0757-7","journal-title":"Pituitary"},{"key":"1384_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01266-w","author":"AM Isidori","year":"2020","unstructured":"Isidori AM, Arnaldi G, Boscaro M et al (2020) COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-020-01266-w","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1384_CR41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3109\/03602532.2010.484462","volume":"42","author":"Z Dvorak","year":"2010","unstructured":"Dvorak Z, Pavek P (2010) Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids. Drug Metab Rev 42(4):621\u2013635. https:\/\/doi.org\/10.3109\/03602532.2010.484462","journal-title":"Drug Metab Rev"},{"issue":"3","key":"1384_CR42","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1517\/17425255.2014.878703","volume":"10","author":"P Matoulkov\u00e1","year":"2014","unstructured":"Matoulkov\u00e1 P, P\u00e1vek P, Mal\u00fd J, Vl\u010dek J (2014) Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interaction. Expert Opin Drug Metab Toxicol 10(3):425\u2013435. https:\/\/doi.org\/10.1517\/17425255.2014.878703","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1384_CR43","doi-asserted-by":"publisher","first-page":"108409","DOI":"10.1016\/j.clim.2020.108409","volume":"2","author":"A Gasmi","year":"2020","unstructured":"Gasmi A, Noor S, Tippairote T, Dadar M, Menzel A, Bj\u00f8rklund G (2020) Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Clin Immunol 2:108409","journal-title":"Clin Immunol"},{"issue":"5","key":"1384_CR44","doi-asserted-by":"publisher","first-page":"412","DOI":"10.7861\/clinmedicine.16-5-412","volume":"16","author":"ER Elliot","year":"2016","unstructured":"Elliot ER, Theodoraki A, Jain LR et al (2016) Iatrogenic Cushing\u2019s syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies. Clin Med (Northfield Il) 16(5):412\u2013418. https:\/\/doi.org\/10.7861\/clinmedicine.16-5-412","journal-title":"Clin Med (Northfield Il)"},{"issue":"9","key":"1384_CR45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/hiv.12039","volume":"14","author":"P Saberi","year":"2013","unstructured":"Saberi P, Phengrasamy T, Nguyen DP (2013) Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management. HIV Med 14(9):519\u2013529. https:\/\/doi.org\/10.1111\/hiv.12039","journal-title":"HIV Med"},{"issue":"1","key":"1384_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s40064-015-1218-x","volume":"4","author":"N Epperla","year":"2015","unstructured":"Epperla N, McKiernan F (2015) Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone. Springerplus 4(1):455. https:\/\/doi.org\/10.1186\/s40064-015-1218-x","journal-title":"Springerplus"},{"issue":"5","key":"1384_CR47","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1530\/EJE-15-0608","volume":"173","author":"CP Woods","year":"2015","unstructured":"Woods CP, Argese N, Chapman M et al (2015) Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Eur J Endocrinol 173(5):633\u2013642. https:\/\/doi.org\/10.1530\/EJE-15-0608","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1384_CR48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/jinf.2001.0928","volume":"44","author":"P Clevenbergh","year":"2002","unstructured":"Clevenbergh P, Corcostegui M, G\u00e9rard D et al (2002) Iatrogenic Cushing\u2019s Syndrome in an HIV-Infected patient treated with Inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen. J Infect 44(3):194\u2013195. https:\/\/doi.org\/10.1053\/jinf.2001.0928","journal-title":"J Infect"},{"issue":"6","key":"1384_CR49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1468-1293.2008.00579.x","volume":"9","author":"MM Foisy","year":"2008","unstructured":"Foisy MM, Yakiwchuk EMK, Chiu I, Singh AE (2008) Adrenal suppression and Cushing\u2019s syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med 9(6):389\u2013396. https:\/\/doi.org\/10.1111\/j.1468-1293.2008.00579.x","journal-title":"HIV Med"},{"issue":"7","key":"1384_CR50","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1210\/jc.2005-0036","volume":"90","author":"K Samaras","year":"2005","unstructured":"Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA (2005) Iatrogenic cushing\u2019s syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and Ritonavir-Boosted protease inhibitors: six cases. J Clin Endocrinol Metab 90(7):4394\u20134398. https:\/\/doi.org\/10.1210\/jc.2005-0036","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1384_CR51","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1089\/apc.2006.0117","volume":"21","author":"RM Germain","year":"2007","unstructured":"Germain RM, Yigit S, Wells L, Giratto JE, Salazar JC (2007) Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent. AIDS Patient Care STDS. 21(6):373\u2013377. https:\/\/doi.org\/10.1089\/apc.2006.0117","journal-title":"AIDS Patient Care STDS."},{"issue":"6","key":"1384_CR52","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.endinu.2017.02.006","volume":"64","author":"I Zubillaga","year":"2017","unstructured":"Zubillaga I, Franc\u00e9s C, Nicolau J, Homar F, Masmiquel L (2017) Adrenal insufficiency and exogenous Cushing\u2019s syndrome in a patient receiving inhaled fluticasone and ritonavir. Endocrinol Diabetes y Nutr 64(6):338\u2013339. https:\/\/doi.org\/10.1016\/j.endinu.2017.02.006","journal-title":"Endocrinol Diabetes y Nutr"},{"issue":"9","key":"1384_CR53","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2165\/00002018-200831090-00005","volume":"31","author":"M Molimard","year":"2008","unstructured":"Molimard M, Girodet P-O, Pollet C et al (2008) Inhaled Corticosteroids and Adrenal Insufficiency. Drug Saf 31(9):769\u2013774. https:\/\/doi.org\/10.2165\/00002018-200831090-00005","journal-title":"Drug Saf"},{"key":"1384_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1530\/edm-16-0158","volume":"20","author":"SAA van den Berg","year":"2020","unstructured":"van den Berg SAA, van Veer NE, Emmen JMA, van Beek RHT (2020) Fluticasone furoate induced iatrogenic Cushing syndrome in a pediatric patient receiving anti-retroviral therapy. Endocrinol Diabetes Metab Case Reports 20:5\u20138. https:\/\/doi.org\/10.1530\/edm-16-0158","journal-title":"Endocrinol Diabetes Metab Case Reports"},{"issue":"7","key":"1384_CR55","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3109\/02770903.2010.485666","volume":"47","author":"E Kedem","year":"2010","unstructured":"Kedem E, Shahar E, Hassoun G, Pollack S (2010) Iatrogenic Cushing\u2019s syndrome due to coadministration of Ritonavir and Inhaled Budesonide in an Asthmatic human immunodeficiency virus infected patient. J Asthma 47(7):830\u2013831. https:\/\/doi.org\/10.3109\/02770903.2010.485666","journal-title":"J Asthma"},{"issue":"4","key":"1384_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/2325957414567681","volume":"14","author":"BR Wood","year":"2015","unstructured":"Wood BR, Lacy JM, Johnston C, Weigle DS, Dhanireddy S (2015) Adrenal insufficiency as a result of ritonavir and exogenous steroid exposure : report of 6 cases and recommendation for management. J Int Assoc Provid AIDS Care 14(4):300\u2013305. https:\/\/doi.org\/10.1177\/2325957414567681","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"6","key":"1384_CR57","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/2325957417736612","volume":"16","author":"L Colpitts","year":"2017","unstructured":"Colpitts L, Murray TB, Tahhan SG, Boggs JP (2017) Iatrogenic Cushing Syndrome in a 47-Year-Old HIV-positive woman on ritonavir and inhaled Budesonide. J Int Assoc Provid AIDS Care 16(6):531\u2013534. https:\/\/doi.org\/10.1177\/2325957417736612","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"9","key":"1384_CR58","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1177\/0956462413480723","volume":"24","author":"JJ Hall","year":"2013","unstructured":"Hall JJ, Hughes CA, Foisy MM, Houston S, Shafran S (2013) Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir. Int J STD AIDS 24(9):748\u2013752. https:\/\/doi.org\/10.1177\/0956462413480723","journal-title":"Int J STD AIDS"},{"issue":"10","key":"1384_CR59","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/QAD.0b013e328347c09c","volume":"25","author":"A Molloy","year":"2011","unstructured":"Molloy A, Matheson NJ, Meyer PA, Chaterjee K, Gkrania-Klotsas E (2011) Cushing\u02bcs syndrome and adrenal axis suppression in a patient treated with ritonavir and corticosteroid eye drops. AIDS 25(10):1337\u20131339. https:\/\/doi.org\/10.1097\/QAD.0b013e328347c09c","journal-title":"AIDS"},{"key":"1384_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-6405-6-10","volume":"6","author":"K Dort","year":"2009","unstructured":"Dort K, Padia S, Wispelwey B, Moore CC (2009) Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report. AIDS Res Ther 6:4\u20137. https:\/\/doi.org\/10.1186\/1742-6405-6-10","journal-title":"AIDS Res Ther"},{"key":"1384_CR61","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1136\/bcr.02.2012.5849","volume":"3","author":"HZR McConkey","year":"2013","unstructured":"McConkey HZR, Williams H, Kulasegaram R, Graham E (2013) Orbital floor triamcinolone causing Cushing\u2019s syndrome in a patient treated with Kaletra for HIV 1. BMJ Case Rep. 3:2012\u20132014. https:\/\/doi.org\/10.1136\/bcr.02.2012.5849","journal-title":"BMJ Case Rep."},{"issue":"6","key":"1384_CR62","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s15010-013-0506-z","volume":"41","author":"C Schwarze-Zander","year":"2013","unstructured":"Schwarze-Zander C, Klingm\u00fcller D, Kl\u00fcmper J, Strassburg CP, Rockstroh JK (2013) Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature. Infection 41(6):1183\u20131187. https:\/\/doi.org\/10.1007\/s15010-013-0506-z","journal-title":"Infection"},{"issue":"6","key":"1384_CR63","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/2325957413488187","volume":"13","author":"Y Song","year":"2014","unstructured":"Song Y, Schroeder JR, Bush LM (2014) Iatrogenic cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review. J Int Assoc Provid AIDS Care 13(6):511\u2013514. https:\/\/doi.org\/10.1177\/2325957413488187","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"1","key":"1384_CR64","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/MAJ.0b013e31824ceb2b","volume":"344","author":"NE Albert","year":"2012","unstructured":"Albert NE, Kazi S, Santoro J, Dougherty R (2012) Ritonavir and epidural triamcinolone as a cause of iatrogenic cushing\u2019s syndrome. Am J Med Sci 344(1):72\u201374. https:\/\/doi.org\/10.1097\/MAJ.0b013e31824ceb2b","journal-title":"Am J Med Sci"},{"key":"1384_CR65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4172\/jaa.1000086","volume":"05","author":"G John","year":"2013","unstructured":"John G, Patrick M, Ollo D (2013) Clinical course and management of iatrogenic Cushing\u2019s syndrome after co-administration of injected-triamcinolone and Ritonavir: a systematic review. J Antivir Antiretrovir 05:7. https:\/\/doi.org\/10.4172\/jaa.1000086","journal-title":"J Antivir Antiretrovir"},{"issue":"11","key":"1384_CR66","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1093\/jac\/dkz324","volume":"74","author":"L Peyro-Saint-Paul","year":"2019","unstructured":"Peyro-Saint-Paul L, Besnier P, Demessine L et al (2019) Cushing\u2019s syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case-control study in the French Pharmacovigilance Database. J Antimicrob Chemother 74(11):3291\u20133294. https:\/\/doi.org\/10.1093\/jac\/dkz324","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1384_CR67","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/QAI.0b013e31817bebeb","volume":"48","author":"KH Busse","year":"2008","unstructured":"Busse KH, Formentini E, Alfaro RM, Kovacs JA, Penzak SR (2008) Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals. J Acquir Immune Defic Syndr 48(5):561\u2013566. https:\/\/doi.org\/10.1097\/QAI.0b013e31817bebeb","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"1384_CR68","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/01.qai.0000187444.38461.70","volume":"40","author":"SR Penzak","year":"2005","unstructured":"Penzak SR, Formentini E, Alfaro RM, Long M, Natarajan V, Kovacs J (2005) Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers. JAIDS J Acquir Immune Defic Syndr 40(5):573\u2013580. https:\/\/doi.org\/10.1097\/01.qai.0000187444.38461.70","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"1384_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/HIV.S52266","volume":"6","author":"KA Oshikoya","year":"2014","unstructured":"Oshikoya KA, Oreagba IA, Lawal S et al (2014) Potential drug-drug interactions in HIV-infected children on antiretroviral therapy in Lagos. Nigeria HIV\/AIDS Res Palliat Care 6:49\u201359. https:\/\/doi.org\/10.2147\/HIV.S52266","journal-title":"Nigeria HIV\/AIDS Res Palliat Care"},{"issue":"2","key":"1384_CR70","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jac\/dks404","volume":"68","author":"M Sharma","year":"2013","unstructured":"Sharma M, Saravolatz LD (2013) Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor. J Antimicrob Chemother 68(2):250\u2013256. https:\/\/doi.org\/10.1093\/jac\/dks404","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1384_CR71","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00228-019-02626-z","volume":"75","author":"D Cattaneo","year":"2019","unstructured":"Cattaneo D, Cheli S, Fusi M, Clementi E, Gervasoni C (2019) Different effects of glucocorticoids on darunavir plasma concentrations. Eur J Clin Pharmacol 75(5):733\u2013735. https:\/\/doi.org\/10.1007\/s00228-019-02626-z","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"1384_CR72","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1002\/art.39194","volume":"67","author":"M Jallouli","year":"2015","unstructured":"Jallouli M, Galicier L, Zahr N et al (2015) Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus. Arthritis Rheumatol 67(8):2176\u20132184. https:\/\/doi.org\/10.1002\/art.39194","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"1384_CR73","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.taap.2011.03.019","volume":"253","author":"AS Flaman","year":"2011","unstructured":"Flaman AS, Gravel C, Hashem AM, Tocchi M, Li X (2011) The effect of interferon-\u03b1 on the expression of cytochrome P450 3A4 in human hepatoma cells. Toxicol Appl Pharmacol 253(2):130\u2013136. https:\/\/doi.org\/10.1016\/j.taap.2011.03.019","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"1384_CR74","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/jhep.1996.v24.pm0008690406","volume":"24","author":"M Tapner","year":"1996","unstructured":"Tapner M, Liddle C, Goodwin B, George J, Farrell GC (1996) Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology 24(2):367\u2013373. https:\/\/doi.org\/10.1053\/jhep.1996.v24.pm0008690406","journal-title":"Hepatology"},{"issue":"5","key":"1384_CR75","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/mp.2008.58","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Borisov AS, Woolwine BJ, Massung B, Vogt G, Miller AH (2010) Interferon-\u03b1 effects on diurnal hypothalamic\u2013pituitary\u2013adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry 15(5):535\u2013547. https:\/\/doi.org\/10.1038\/mp.2008.58","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1384_CR76","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0168-8278(96)80034-1","volume":"24","author":"M Carelli","year":"1996","unstructured":"Carelli M, Porras MC, Rizzardini M, Cantoni L (1996) Modulation of constitutive and inducible hepatic cytochrome(s) P-450 by interferon \u03b2 in mice. J Hepatol 24(2):230\u2013237. https:\/\/doi.org\/10.1016\/S0168-8278(96)80034-1","journal-title":"J Hepatol"},{"issue":"8","key":"1384_CR77","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0306-4530(01)00099-3","volume":"27","author":"M Goebel","year":"2002","unstructured":"Goebel M, Baase J, Pithan V et al (2002) Acute interferon \u03b2-1b administration alters hypothalamic-pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects. Psychoneuroendocrinology 27(8):881\u2013892. https:\/\/doi.org\/10.1016\/S0306-4530(01)00099-3","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"1384_CR78","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2265.2006.02725.x","volume":"66","author":"F Then Bergh","year":"2007","unstructured":"Then Bergh F, K\u00fcmpfel T, Yassouridis A, Lechner C, Holsboer F, Trenkwalder C (2007) Acute and chronic neuroendocrine effects of interferon-beta 1a in multiple sclerosis. Clin Endocrinol (Oxf) 66(2):295\u2013303. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02725.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1384_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01279-5","author":"AM Isidori","year":"2020","unstructured":"Isidori AM, Jannini EA, Lenzi A, Ghigo E (2020) The Italian Endo-COVID-19. Our response to the emergency. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-020-01279-5","journal-title":"J Endocrinol Invest"},{"key":"1384_CR80","doi-asserted-by":"publisher","first-page":"ajh25829","DOI":"10.1002\/ajh.25829","volume":"1","author":"E Terpos","year":"2020","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I et al (2020) Hematological findings and complications of COVID -19. Am J Hematol 1:ajh25829. https:\/\/doi.org\/10.1002\/ajh.25829","journal-title":"Am J Hematol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01384-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T23:28:17Z","timestamp":1630106897000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01384-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01384-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflicts of interest that might be perceived as influencing the impartiality of the reported research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Informed consent is not necessary in a review-publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}